Pharmaron Beijing Market Cap

Pharmaron Beijing has a market cap or net worth of 50.60 billion as of August 14, 2025. Its market cap has increased by 56.82% in one year.

Market Cap

50.60B

Enterprise Value

54.47B

Revenue

12.70B

Ranking

n/a

PE Ratio

28.58

Stock Price

30.19

Market Cap Chart

Since January 28, 2019, Pharmaron Beijing's market cap has increased from 7.24B to 50.60B, an increase of 598.94%. That is a compound annual growth rate of 34.57%.

Market Cap History

Date	Market Cap	% Change
Aug 14, 2025	50.61B	20.94%
Dec 31, 2024	41.85B	-11.66%
Dec 29, 2023	47.37B	-38.44%
Dec 30, 2022	76.95B	-27.67%
Dec 31, 2021	106.40B	12.84%
Dec 31, 2020	94.29B	140.25%
Dec 31, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Jiangsu Hengrui Medicine	405.72B
Shenzhen Mindray Bio-Medical Electronics	283.36B
WuXi AppTec	267.28B
Zhangzhou Pientzehuang Pharmaceutical.,	121.39B
Aier Eye Hospital Group	121.03B
Sichuan Biokin Pharmaceutical	118.80B
Shanghai United Imaging Healthcare	107.46B
Yunnan Baiyao Group Co.,Ltd	99.83B

Market Cap Rankings